CIAM
BJDX icon

Caitong International Asset Management’s Bluejay Diagnostics BJDX Stock Holding History

Caitong International Asset Management’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Sell
1
-2
-67% -$5 ﹤0.01% 2855
2026
Q1 		$6 Buy
+3
New +$7 ﹤0.01% 2223

Other funds holding BJDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM

Caitong International Asset Management's BJDX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Bluejay Diagnostics (BJDX) stake by 67% in Q2 2026, selling an estimated $5 and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Caitong International Asset Management first reported a position in BJDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $6 in Q1 2026. 8 funds tracked by Wall St. Rank hold BJDX as of Q2 2026.

  • Caitong International Asset Management held 1 share of Bluejay Diagnostics worth $1 as of Q2 2026.
  • Caitong International Asset Management sold 2 Bluejay Diagnostics shares in Q2 2026, an estimated $5.
  • Bluejay Diagnostics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2855 holding.
  • Caitong International Asset Management first reported a position in Bluejay Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • Caitong International Asset Management's Bluejay Diagnostics position peaked at $6 in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.